Zobrazeno 1 - 10
of 136
pro vyhledávání: '"O, Nome"'
Autor:
Bengt Glimelius, Ingrid Glimelius, Anita Gustavsson, Martin Erlanson, Lisa Åkesson, Cecilia Raud, Helena Fohlin, Ingemar Lagerlöf, Alexander Fosså, Bjørn Østenstad, Magnus Björkholm, Johan Linderoth, Daniel Molin, Ann-Sofie Johansson, Gunilla Enblad, Christina Goldkuhl, Harald Holte, Øystein Fluge, O. Nome, Marzia Palma
Publikováno v:
British Journal of Haematology. 188:685-691
When treating limited stage classical Hodgkin lymphoma (cHL), balancing treatment efficacy and toxicity is important. Toxicities after extended-field radiotherapy are well documented. Investigators have aimed at reducing toxicity without compromising
Publikováno v:
Leukemia & Lymphoma. 48:570-576
There is no consensus on the optimal chemotherapy regimen for Hodgkin's lymphoma patients > or = 60 years. We present our institution's results of 5 years, using CHOP-21 as standard for this patient group. Twenty-nine patients with a median age of 71
Publikováno v:
European Journal of Cancer. 36:1762-1768
We examined retrospectively the outcome of patients with non-Hodgkin's lymphoma (NHL) with systemic involvement of the central nervous system (CNS) registered at The Norwegian Radium Hospital (NRH) from 1980 to 1996, in order to evaluate our treatmen
Publikováno v:
Acta Oncologica. 39:865-872
We report long-term survival and prognostic factors in 252 patients with stage I high-grade lymphoma. Median patient age was 64 years and 49% of patients had extranodal lymphoma. Premenopausal women had less risk of extranodal lymphoma than older wom
Autor:
Jon Håvard Loge, Stein Kvaløy, Harald Holte, May Brit Lund, E. Hannisdal, A. F. Abrahamsen, O. Nome
Publikováno v:
Acta Oncologica. 38:511-515
A total of 221 consecutive early stage Hodgkin's disease (HD) patients were given mantle field irradiation only or in combination with chemotherapy in 1971-1991. In 1994 these patients responded to a mailed self-report questionnaire covering items on
Autor:
Halfdan Ihlen, May Brit Lund, Johny Kongerud, K. Forfang, M. Stugaard, A. F. Abrahamsen, B. M. R. Voss, O. Nome
Publikováno v:
Heart. 75:591-595
OBJECTIVE: To assess by echocardiography the occurrence and degree of late cardiac sequelae after treatment for Hodgkin's disease by radiation and chemotherapy. PATIENTS AND METHODS: In Norway from 1980 to 1988, 129 patients < 50 years old with Hodgk
Publikováno v:
Annals of Oncology. 7:257-264
Summary Background: The treatment of Hodgkin's disease (HD) involves irradiation and chemotherapy. Both modalities may cause heart and lung injury. We aimed to assess 1) the occurrence of such injury, 2) the extent to which combined versus single-org
Autor:
Bjarne Hager, O. Nome, Harald Holte, Stein Kvaløy, E. Hannisdal, Ruth Langholm, A. Foss Abrahamsen
Publikováno v:
Annals of Oncology. 7:145-150
Summary Background We concluded a program in which we administered radiotherapy only to clinical stages I and II Hodgkin's disease patients at standard risk, with the addition of 4 cycles of combination chemotherapy before radiotherapy for high-risk
Publikováno v:
Acta Oncologica. 32:307-310
Survival was analyzed in 173 patients with malignant gliomas to study the importance of possible pretreatment prognostic factors. Seventy-nine of these patients received preirradiation intra-arterial chemotherapy with BCNU combined with vincristine i
Autor:
O. Nome, Aase Hollender, Ida Ikonomo, Trond Warloe, Harald Holte, Marianne Jensen Hjermstad, Stein Kvaløy, Karl Otto Karlsen
Publikováno v:
Acta oncologica (Stockholm, Sweden). 45(2)
Up to 90% of patients with localized non-Hodgkin's lymphomas (NHL) in the gastrointestinal tract (GI) are cured and decreased use of radical surgery is favoured. Although quality of life (QOL) may impact treatment choice, little is known about QOL in